May 5, 2022 – Joe DiMaggio Children’s Hospital recently announced the successful treatment of a patient with atrial septal defects (ASD), or opening defect in the wall of the heart that separates the ...
Structural Heart Occluders
This channel includes news and new technology innovations about structural heart occluders. These include information of surgical repair and transcatheter closure of PFO, VSD, ASD and LAA. Devices include the Amplatzer and the Gore Helex
June 20, 2024 — atHeart Medical, a medical device company establishing a new standard of care for atrial septal defects ...
July 14, 2023 — In recent years, transcatheter intervention techniques have emerged as a promising alternative for the ...
February 27, 2023 — Conformal Medical, Inc. announced today the results from the CONFORMAL Early Feasibility Study (EFS) ...
May 5, 2022 – Joe DiMaggio Children’s Hospital recently announced the successful treatment of a patient with atrial ...
February 18, 2022 – Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of ...
January 17, 2022 – As the increasing number of structural heart interventions are assisted by real-time imaging guidance ...
November 8, 2021 – SWISS-APERO is the first randomized clinical trial comparing the Abbott Amulet left atrial appendage ...
October 4, 2021 — U.S. Food and Drug Administration (FDA) has cleared the Abbott Amplatzer Talisman PFO Occlusion System ...
![Illustration of the Watchman transcatheter left atrial appendage (LAA) occluder being  deployed into the LAA. FDA is concerned about higher rates of LAA occlusion complications in women compared to men, prompting the FDA to send a letter to providers warning them on possible poor outcomes.](/sites/default/files/styles/content_feed_large/public/field/image/X0000_Boston_Scientific_WATCHMAN%20Left%20Atrial%20Appendage%20Closure%20Device%20Implant%20hi-res%203_0.jpg?itok=LMS-2Hka)
September 27, 2021 — Compared with men undergoing left atrial appendage occlusion (LAAO), women have a significantly ...
![The U.S. Food and Drug Administration (FDA) has cleared the company's Portico with FlexNav transcatheter aortic valve replacement (TAVR) system to treat people with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery.Â](/sites/default/files/styles/content_feed_large/public/field/image/Abbott_Portico_TAVR_gradient_1200x628%20copy.jpg?itok=NNSa043J)
September 20, 2021 — Abbott announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Portico ...
August 31, 2021 — Late-breaking data from a head-to-head clinical trial of the Amulet Left Atrial Appendage (LAA) ...
August 16, 2021 — The U.S. Food and Drug Administration (FDA) approved Abbott's Amplatzer Amulet Left Atrial Appendage ...
![CentraCare completed the first structural heart procedure in the world guided by a new 4-D hologram technology developed by EchoPixel. The augmented reality technology aims to reduce reduce procedure time, improve accuracy of the procedure, and reduce risk of complications.](/sites/default/files/styles/content_feed_large/public/field/image/Echopixel_intra-operative_Holographic_Therapy_Guidance_HTG_Platform%20copy.jpg?itok=bUAUAsSu)
June 28, 2021 — CentraCare, one of the largest health systems in Minnesota, successfully completed the first structural ...
Tom Jones, M.D., director, cardiac catheterization laboratories, Seattle Children’s Hospital, explains some of the new ...
![The Boston Scientific Watchman device have performed better than expected in real-world patients outside of trials since it was introduced in 2015, according to data from the NCDR LAAO Registry. #ACC21 #ACC2021 #LAA #Watchman](/sites/default/files/styles/content_feed_large/public/field/image/Boston_Scientific___Watchman_2_FLX2_0.jpg?itok=gcOs3nnc)
May 15, 2021 - Transcatheter left atrial appendage occlusion (LAAO) with a Boston Scientific Watchman device was ...